Patents by Inventor Chen Shaowu

Chen Shaowu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CCR9 inhibitors and methods of use thereof
    Patent number: 7659272
    Abstract: The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: February 9, 2010
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Paul Fleming, Geraldine C. B. Harriman, Zhan Shi, Chen Shaowu
  • CCR9 inhibitors and methods of use thereof
    Publication number: 20080103180
    Abstract: The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
    Type: Application
    Filed: October 16, 2007
    Publication date: May 1, 2008
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Paul Fleming, Geraldine Harriman, Zhan Shi, Chen Shaowu
  • CCR9 inhibitors and methods of use thereof
    Patent number: 7282502
    Abstract: The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: October 16, 2007
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Paul Fleming, Geraldine C. B. Harriman, Zhan Shi, Chen Shaowu